This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Heeg B, Damen J, Van Hout B.Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective. PharmacoEconomics 25: 1063-1082, No. 12, Jan 2007
Rights and permissions
About this article
Cite this article
Value of antiplatelets in the spotlight for secondary prevention. Pharmacoecon. Outcomes News 543, 8 (2007). https://doi.org/10.2165/00151234-200705430-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705430-00020